What are the risks of long-acting beta-agonist (LABA) use in patients with asthma?

MOspace/Manakin Repository

Breadcrumbs Navigation

What are the risks of long-acting beta-agonist (LABA) use in patients with asthma?

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/10741

[+] show full item record


Title: What are the risks of long-acting beta-agonist (LABA) use in patients with asthma?
Author: Heinz, Erich
Date: 2011-05
Publisher: Family Physicians Inquiries Network
Citation: Evidence Based Practice 14(5): 09.
Series/Report no.: Help Desk Answers
Abstract: Two recent meta-analyses have conflicting results. One found an increased risk of asthma-related intubation and death when LABAs are used alone or in combination with inhaled corticosteroids (ICS). A second systematic review found improved asthma-related outcomes when adding LABAs to ICS in adult patients with inadequately controlled asthma. These reviews differed in their primary endpoints and inclusion criteria.
URI: http://hdl.handle.net/10355/10741

This item appears in the following Collection(s)

[+] show full item record